← Leaderboards
Christine Marie Durand
Johns Hopkins University
$23,429,807
Attributed
$46,369,860
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.4M · FY2014–25$20M$15M$10M$5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,369,860 · 6
By mechanism
U01$45,318,820 · 4
K23$808,040 · 1
R34$243,000 · 1
Top collaborators
- Dorry Segev23 shared
- Aaron A Tobian1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- David L Thomas$44,227,388
- Andrea L Cox$41,369,991
- Dorry Segev$40,743,790
- Shruti H Mehta$41,677,787
- Chris Beyrer$53,118,025
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationInfectionViralOrganData ManagementOperationKidney TransplantationKidneyVirologyCommunicable DiseasesEventTransplant CentersEnrollmentEnsureBloodTransplant RecipientsDesignInfrastructureMediatingInsightClinical TrialsPathologyIncidenceMalignant Neoplasms
Grant awards (29)
Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes$1,715,945
U01 · FY2025 · AI · contact PI
Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk$1,683,861
U01 · FY2025 · AI · contact PI
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)$1,359,557
U01 · FY2025 · AI · contact PI
Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes$1,727,039
U01 · FY2024 · AI · contact PI
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)$1,388,200
U01 · FY2024 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$6,700,000
U01 · FY2023 · AI · contact PI
Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes$1,781,226
U01 · FY2023 · AI · contact PI
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)$1,389,503
U01 · FY2023 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$1,673,554
U01 · FY2022 · AI · contact PI
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)$1,025,696
U01 · FY2022 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$126,471
U01 · FY2022 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$30,644
U01 · FY2022 · AI · contact PI
COVID Protection After Transplant (CPAT) Multicenter Adaptive Trial$6,941,821
U01 · FY2021 · AI · contact PI
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation$3,366,438
U01 · FY2021 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$1,651,121
U01 · FY2021 · AI · contact PI
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation$1,416,143
U01 · FY2021 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$1,676,011
U01 · FY2020 · AI · contact PI
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation$1,518,324
U01 · FY2020 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$1,686,376
U01 · FY2019 · AI · contact PI
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation$1,544,393
U01 · FY2019 · AI · contact PI
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation$1,778,541
U01 · FY2018 · AI · contact PI
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation$1,559,239
U01 · FY2018 · AI · contact PI
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection$161,608
K23 · FY2018 · CA · contact PI
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation$1,578,717
U01 · FY2017 · AI · contact PI
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection$161,608
K23 · FY2017 · CA · contact PI
HOPE in Action: HIV-to-HIV Solid Organ Transplantation in the US$243,000
R34 · FY2016 · AI · contact PI
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection$161,608
K23 · FY2016 · CA · contact PI
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection$161,608
K23 · FY2015 · CA · contact PI
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection$161,608
K23 · FY2014 · CA · contact PI